4.7 Article

Carbamylation of Integrin αIIbβ3: The Mechanistic Link to Platelet Dysfunction in ESKD

期刊

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
卷 33, 期 10, 页码 1841-1856

出版社

AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2022010013

关键词

-

资金

  1. National Science Center (Poland)
  2. Helse Vest open project [2019/33/B/NZ4/01889]
  3. Norwegian Research Council [303567]
  4. Broegelmann Foundation [296129]
  5. National Institutes of Health
  6. [R35GM118112]

向作者/读者索取更多资源

The study explored carbamylation as a potential mechanistic link between uremia and platelet dysfunction in patients with ESKD, revealing that carbamylation inhibited platelet activation, adhesion, and aggregation.
Background: Bleeding diatheses, common among patients with ESKD, can lead to serious complications, particularly during invasive procedures. Chronic urea overload significantly increases cyanate concentrations in patients with ESKD, leading to carbamylation, an irreversible modification of proteins and peptides. Methods: To investigate carbamylation as a potential mechanistic link between uremia and platelet dysfunction in ESKD, we used liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) to quantify total homocitrulline, and biotin-conjugated phenylglyoxal labeling and Western blot to detect carbamylated integrin alpha(IIb)beta(3) (a receptor required for platelet aggregation). Flow cytometry was used to study activation of isolated platelets and platelet-rich plasma. In a transient transfection system, we tested activity and fibrinogen binding of different mutated forms of the receptor. We assessed platelet adhesion and aggregation in microplate assays. Results: Carbamylation inhibited platelet activation, adhesion, and aggregation. Patients on hemodialysis exhibited significantly reduced activation of alpha(IIb)beta(3) compared with healthy controls. We found significant carbamylation of both subunits of alpha(IIb)beta(3) on platelets from patients receiving hemodialysis versus only minor modification in controls. In the transient transfection system, modification of lysine 185 in the beta(3) subunit was associated with loss of receptor activity and fibrinogen binding. Supplementation of free amino acids, which was shown to protect plasma proteins from carbamylation-induced damage in patients on hemodialysis, prevented loss of alpha(IIb)beta(3) activity in vitro. Conclusions: Carbamylation of alpha(IIb)beta(3)-specifically modification of the K185 residue-might represent a mechanistic link between uremia and dysfunctional primary hemostasis in patients on hemodialysis. The observation that free amino acids prevented the carbamylation-induced loss of alpha(IIb)beta(3) activity suggests amino acid administration during dialysis may help to normalize platelet function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据